From Mendel to Medical Genetics: Milan Macek Jr. to Share Rare Disease Insights at ECTH 2025
European Congress on Thrombosis and Haemostasis (ECTH) posted on LinkedIn:
”From the legacy of Mendel to the frontlines of rare disease advocacy, Professor Milan Macek Jr., MD, DSc, is a true pioneer in medical genetics. As chair of the Czech Republic’s largest academic genetics centre and head of the National Coordination Centre for Rare Diseases, he’s shaping not just science, but national health strategies.
At ECTH 2025, Professor Milan Macek Jr. will take us on a journey through his session “From Mendel to medical genetics”, exploring how genetic breakthroughs are transforming diagnostics, care, and policy for rare diseases.
Expect a session that’s as visionary as it is practical; bridging history, cutting-edge research, and the real-world impact of coordinated action.
Join us at ECTH 2025.”
Stay updated with Hemostasis Today.
-
Feb 23, 2026, 15:59Ney Carter Borges: Antithrombotic Therapy in 2025 – A Precision-Based Pharmacologic Update
-
Feb 23, 2026, 15:54Alan Nurden: From Early Discoveries to New Therapeutic Advances in von Willebrand Disease
-
Feb 23, 2026, 15:52Gevorg Tamamyan: Albania’s Vision for the Future of Pediatric Oncology
-
Feb 23, 2026, 15:36Simon Senanu: The Peripheral Blood Smear as an Essential Diagnostic Tool in Modern Medicine
-
Feb 23, 2026, 15:32Cheng-Hock Toh: The Paradox of Hematology
-
Feb 23, 2026, 15:20Rabab Al Dawood: Moderating the Coagulation and Hemostasis Session at the ISLH 1st Joint Conference
-
Feb 23, 2026, 15:16Amira Khater: Key Updates on Pulmonary Embolism Management from AHA and ACC Guidelines
-
Feb 23, 2026, 14:45Stacey McGeown: Rare Disease Awareness Day at QUB Marks the Start of Rare Disease Month
-
Feb 23, 2026, 13:53Rare Diseases, Plasma-Derived Medicines and the Elephant in the Room – Part 1